GlassScriptPhysician profile
David Huneycutt
NPI 1902823859
$2,629.08
in general payments reported to CMS, 2019-2025
21 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $94.52 · 2021: $99.69 · 2022: $753 · 2023: $512 · 2024: $622 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viz.Ai, INC. | $616.50 | 2022 | |
| Pfizer INC. | $269.10 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $243.92 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $203.43 | 2023-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $201.09 | 2022-2025 | Cds - Mct/Cem Monitoring |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.28 | 2019-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $140.33 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $138.18 | 2019-2025 | Leqvio |
| Astrazeneca Pharmaceuticals LP | $136.76 | 2023-2025 | Wainua, Farxiga, Lokelma |
| Heartflow, INC. | $136.63 | 2022-2025 | Ffrct |
| Novo Nordisk INC | $92.64 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lexicon Pharmaceuticals, INC. | $57.78 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $54.44 | 2023 | Arcalyst |
| Medtronic Vascular, INC. | $34.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $28.10 | 2019-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.86 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Esperion Therapeutics, INC. | $24.17 | 2021 | |
| Inspire Medical Systems, INC. | $22.77 | 2023 | Inspire |
| Edwards Lifesciences Corporation | $19.36 | 2022 | |
| Abiomed | $18.79 | 2023 | Impella |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Huneycutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.